rs146290726
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003476.5(CSRP3):c.300C>T(p.Arg100Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R100R) has been classified as Likely benign.
Frequency
Consequence
NM_003476.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD, SD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
- hypertrophic cardiomyopathy 12Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- dilated cardiomyopathy 1MInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000394  AC: 6AN: 152202Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000119  AC: 3AN: 251354 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000342  AC: 5AN: 1461890Hom.:  0  Cov.: 32 AF XY:  0.00000138  AC XY: 1AN XY: 727248 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000394  AC: 6AN: 152202Hom.:  0  Cov.: 32 AF XY:  0.0000538  AC XY: 4AN XY: 74358 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1M;C2677491:Hypertrophic cardiomyopathy 12    Benign:1 
- -
Cardiovascular phenotype    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at